Tech billionaire Peter Thiel has invested in British health tech startup Lindus Health. The London-based company has now raised around $6 million to date. Check out the 18-slide pitch deck Lindus ...

Results from a landmark clinical trial this summer suggested, for the first time, that a medication given for weight loss alone could reduce the risk of heart attack, stroke or heart-related death ...

Positive alternative endpoint findings did not correlate highly with OS or QoL endpoints. The researchers suggest that late-phase clinical trial design should focus on OS and QoL improvements to ...

Chemomab Therapeutics has announced that it has successfully completed its End-of-Phase 2 meeting with the FDA, aligning on the design of a single Phase 3 trial for its lead product candidate ...

A new Japanese study of highly purified eicosapentaenoic acid (EPA; icosapent ethyl) has suggested a possible benefit in reducing adverse cardiovascular events in patients with chronic coronary ...